749934-29-0 Usage
Uses
Used in Organic Synthesis:
4-Methoxy-2-fluorobenzyl cyanide is used as a building block in organic synthesis for its ability to contribute to the formation of complex molecular structures. Its unique combination of functional groups allows for versatile reactions and the creation of a wide range of chemical compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, 4-Methoxy-2-fluorobenzyl cyanide is employed as a precursor in the development of new drugs and bioactive molecules. Its structural features make it a valuable component in the synthesis of potential therapeutic agents, contributing to the advancement of medicinal chemistry.
Used in Chemical Intermediates Production:
4-Methoxy-2-fluorobenzyl cyanide is used as a chemical intermediate in the production of various specialty chemicals. Its presence in the synthesis process can lead to the creation of compounds with specific properties required for different applications across various industries.
Used in Research and Development:
In the realm of research and development, 4-Methoxy-2-fluorobenzyl cyanide is utilized to explore new chemical reactions and investigate its potential in creating novel compounds with unique properties. This exploration aids in expanding the knowledge base and capabilities within the chemical and pharmaceutical sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 749934-29-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,9,9,3 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 749934-29:
(8*7)+(7*4)+(6*9)+(5*9)+(4*3)+(3*4)+(2*2)+(1*9)=220
220 % 10 = 0
So 749934-29-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H8FNO/c1-12-8-3-2-7(4-5-11)9(10)6-8/h2-3,6H,4H2,1H3
749934-29-0Relevant academic research and scientific papers
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
-
Page/Page column 223, (2008/06/13)
The invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, solvates, prodrugs and metabolites thereof, wherein W, Z, R1 and R2, are as defined herein. The invention also relates to methods of treating Hepatitis C virus in mammals by administering the compounds of formula 1, and to pharmaceutical compositions for treating such disorders, which contain the compounds of formula 1. The invention also relates to methods of preparing the compounds of formula 1.
